Skip to main content
Top

Current Nutrition Reports

Issue 4/2015

Content (10 Articles)

Cardiovascular Disease (JHY Wu, Section Editor)

Innovative and Collaborative Strategies to Reduce Population-Wide Sodium Intake

Karen E. Charlton, Kelly Langford, Jenny Kaldor

Cardiovascular Disease (JHY Wu, Section Editor)

The Efficacy of Quercetin in Cardiovascular Health

Nicola P. Bondonno, Catherine P. Bondonno, Jonathan M. Hodgson, Natalie C. Ward, Kevin D. Croft

Cardiovascular Disease (JHY Wu, Section Editor)

An Overview of the Role of Metabolomics in the Identification of Dietary Biomarkers

L. Brennan, H. Gibbons, A. O’Gorman

Cardiovascular Disease (JHY Wu, Section Editor)

Front of Pack Nutrition Labelling, Nutrition, Quality and Consumer Choices

Robert Hamlin

Diabetes and Obesity (L Qi, Section Editor)

Epigenetic Determinants of Weight Management: Methylation Signatures

F. I. Milagro, J. I. Riezu-Boj, J. A. Martinez

Diabetes and Obesity (L Qi, Section Editor)

Obesity, Diet and the Gut Microbiota

Anthony R. Bird, Michael A. Conlon

Public Health and Translational Medicine (PW Franks and R Landberg, Section Editors)

Metabolomics for Improved Understanding and Prediction of Cardiometabolic Diseases—Recent Findings from Human Studies

Carl Brunius, Lin Shi, Rikard Landberg

Public Health and Translational Medicine (PW Franks and R Landberg, Section Editors)

Application of Metabolomics to Assess Effects of Controlled Dietary Interventions

Kati Hanhineva

Open Access Public Health and Translational Medicine (PW Franks and R Landberg, Section Editors)

Whole-Blood Gene Expression Profiles in Large-Scale Epidemiological Studies: What Do They Tell?

Karina Standahl Olsen, Guri Skeie, Eiliv Lund

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine